EG210583 Inhibitors
EG210583 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of a molecule or protein known as EG210583. While the detailed biological role of EG210583 may not be completely defined, it is likely involved in critical cellular processes such as enzyme catalysis, signal transduction, or regulatory functions that are essential for maintaining cellular homeostasis. EG210583 could be part of a broader pathway where it interacts with other proteins, nucleic acids, or small molecules, playing a pivotal role in ensuring the proper function and regulation of this pathway. Inhibitors of EG210583 are crafted to bind to this molecule, effectively blocking or altering its activity and thus allowing scientists to explore its function in greater detail.
The action mechanism of EG210583 inhibitors generally involves the binding of these compounds to specific sites on the EG210583 molecule. This binding can occur at the active site if EG210583 functions as an enzyme, preventing it from catalyzing its substrate, or at an allosteric site, where the inhibitor induces conformational changes that reduce or inhibit its activity. Alternatively, if EG210583 interacts with other proteins or molecules within a signaling pathway, the inhibitors might disrupt these interactions, leading to a blockade of downstream signaling events. By inhibiting EG210583, researchers can observe the resulting changes in cellular behavior, which provides critical insights into the specific role that EG210583 plays in various biological processes. This research helps to elucidate the molecular mechanisms governing cellular functions and can reveal the broader impact of EG210583 on cellular systems, including its role in the regulation of complex biochemical networks and its influence on cell physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Direct inhibitor targeting RNA polymerase II, disrupting its activity and preventing transcription initiation. By inhibiting the key enzyme involved in transcription, this compound directly impacts Gm4767's predicted function as a DNA-binding transcription factor. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Direct inhibitor binding to RNA polymerase II, blocking transcription elongation. By hindering RNA polymerase II, this compound directly influences Gm4767's function, as it relies on the polymerase for its predicted activities in DNA binding and transcription regulation. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Direct inhibitor targeting CDK9, a regulator of RNA polymerase II. By inhibiting CDK9, this compound directly affects transcriptional elongation, impacting Gm4767's role in RNA polymerase II-specific DNA binding activity and transcription regulation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Direct inhibitor targeting XPB, a subunit of the transcription factor TFIIH. By inhibiting XPB, this compound directly affects the initiation of transcription, influencing Gm4767's function in RNA polymerase II cis-regulatory region sequence-specific DNA binding. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
CDK inhibitor indirectly influencing Gm4767. By inhibiting CDKs, this compound alters the cell cycle, impacting the availability of RNA polymerase II and influencing Gm4767's function in the regulation of transcription by RNA polymerase II and DNA binding. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Indirect inhibitor affecting Gm4767 through DNA topoisomerase I inhibition. By trapping the enzyme on DNA, this compound indirectly influences RNA polymerase II function, affecting Gm4767's role in DNA binding and transcriptional regulation. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Antimetabolite indirectly impacting Gm4767. By interfering with nucleotide synthesis, this compound indirectly affects RNA polymerase II-dependent transcriptional regulation, influencing Gm4767's function in the regulation of transcription by RNA polymerase II. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor indirectly influencing Gm4767 through chromatin remodeling. By altering histone acetylation, this compound indirectly impacts RNA polymerase II-dependent transcription, affecting Gm4767's role in the regulation of transcription by RNA polymerase II. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Indirect inhibitor influencing Gm4767 through DNA crosslinking. By forming covalent adducts with DNA, this compound indirectly affects RNA polymerase II function, impacting Gm4767's role in DNA binding and the regulation of transcription by RNA polymerase II. | ||||||